Kyowa Kirin Co., Ltd. (4151.T)
JPY 2393.0
(0.46%)
JPY 2393.0
(0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 15.71 Billion JPY | -7.02% |
| 2022 | 16.9 Billion JPY | 0.0% |
| 2021 | - JPY | 0.0% |
| 2020 | - JPY | 0.0% |
| 2019 | - JPY | -100.0% |
| 2018 | 1.11 Billion JPY | -8.8% |
| 2017 | 1.22 Billion JPY | 0.0% |
| 2016 | - JPY | 0.0% |
| 2015 | - JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| 2013 | - JPY | 0.0% |
| 2012 | - JPY | -100.0% |
| 2011 | 98 Million JPY | -62.6% |
| 2010 | 262 Million JPY | -51.21% |
| 2009 | 537 Million JPY | -32.03% |
| 2008 | 790 Million JPY | 311.46% |
| 2007 | 192 Million JPY | -23.2% |
| 2006 | 250 Million JPY | 1983.33% |
| 2005 | 12 Million JPY | -86.05% |
| 2004 | 86 Million JPY | -31.75% |
| 2003 | 126 Million JPY | -99.63% |
| 2002 | 34.07 Billion JPY | -2.35% |
| 2001 | 34.89 Billion JPY | -22.49% |
| 2000 | 45.02 Billion JPY | -22.45% |
| 1999 | 58.06 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - JPY | 0.0% |
| 2024 Q3 | - JPY | 0.0% |
| 2024 Q1 | - JPY | 100.0% |
| 2023 FY | 15.71 Billion JPY | -7.02% |
| 2023 Q1 | - JPY | -100.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2023 Q4 | 15.71 Billion JPY | 0.0% |
| 2022 Q1 | - JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q4 | 16.9 Billion JPY | 0.0% |
| 2022 FY | 16.9 Billion JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2021 FY | - JPY | 0.0% |
| 2021 Q1 | - JPY | 0.0% |
| 2021 Q2 | - JPY | 0.0% |
| 2021 Q3 | - JPY | 0.0% |
| 2021 Q4 | - JPY | 0.0% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 FY | - JPY | 0.0% |
| 2020 Q4 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 Q1 | - JPY | 0.0% |
| 2019 FY | - JPY | -100.0% |
| 2019 Q4 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2019 Q1 | - JPY | -100.0% |
| 2018 FY | 1.11 Billion JPY | -8.8% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q4 | 1.11 Billion JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q1 | - JPY | -100.0% |
| 2017 Q4 | 1.22 Billion JPY | 0.0% |
| 2017 FY | 1.22 Billion JPY | 0.0% |
| 2017 Q1 | - JPY | 0.0% |
| 2017 Q2 | - JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 FY | - JPY | 0.0% |
| 2016 Q4 | - JPY | 0.0% |
| 2016 Q1 | - JPY | 0.0% |
| 2016 Q2 | - JPY | 0.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2015 Q4 | - JPY | 0.0% |
| 2015 Q1 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 FY | - JPY | 0.0% |
| 2014 Q4 | - JPY | 0.0% |
| 2014 Q1 | - JPY | 0.0% |
| 2014 Q3 | - JPY | 0.0% |
| 2014 Q2 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| 2013 Q1 | - JPY | 0.0% |
| 2013 FY | - JPY | 0.0% |
| 2013 Q2 | - JPY | 0.0% |
| 2013 Q3 | - JPY | 0.0% |
| 2013 Q4 | - JPY | 0.0% |
| 2012 FY | - JPY | -100.0% |
| 2012 Q1 | 104 Million JPY | 6.12% |
| 2012 Q2 | 43 Million JPY | -58.65% |
| 2012 Q3 | 43 Million JPY | 0.0% |
| 2012 Q4 | - JPY | -100.0% |
| 2011 Q1 | 265 Million JPY | 1.15% |
| 2011 Q3 | 151 Million JPY | -3.82% |
| 2011 Q2 | 157 Million JPY | -40.75% |
| 2011 FY | 98 Million JPY | -62.6% |
| 2011 Q4 | 98 Million JPY | -35.1% |
| 2010 Q4 | 262 Million JPY | -24.06% |
| 2010 Q1 | 359 Million JPY | 0.0% |
| 2010 Q2 | 376 Million JPY | 4.74% |
| 2010 FY | 262 Million JPY | -51.21% |
| 2010 Q3 | 345 Million JPY | -8.24% |
| 2009 Q3 | 626 Million JPY | -14.13% |
| 2009 FY | 537 Million JPY | -32.03% |
| 2009 Q2 | 729 Million JPY | 0.0% |
| 2008 FY | 790 Million JPY | 311.46% |
| 2007 FY | 192 Million JPY | -23.2% |
| 2006 FY | 250 Million JPY | 1983.33% |
| 2005 FY | 12 Million JPY | -86.05% |
| 2004 FY | 86 Million JPY | -31.75% |
| 2003 FY | 126 Million JPY | -99.63% |
| 2002 FY | 34.07 Billion JPY | -2.35% |
| 2001 FY | 34.89 Billion JPY | -22.49% |
| 2000 FY | 45.02 Billion JPY | -22.45% |
| 1999 FY | 58.06 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Astellas Pharma Inc. | 447.73 Billion JPY | 96.49% |
| Chugai Pharmaceutical Co., Ltd. | 6.48 Billion JPY | -142.531% |
| Ono Pharmaceutical Co., Ltd. | 6.55 Billion JPY | -139.866% |
| Santen Pharmaceutical Co., Ltd. | 27.46 Billion JPY | 42.774% |
| JCR Pharmaceuticals Co., Ltd. | 14.35 Billion JPY | -9.519% |
| Daiichi Sankyo Company, Limited | 101.31 Billion JPY | 84.488% |
| Otsuka Holdings Co., Ltd. | 69.2 Billion JPY | 77.289% |
| Perseus Proteomics Inc. | - JPY | -Infinity% |